MORE NEWS

HEALTHCARE | Staff Reporter, Singapore
Published: 06 Feb 12
522 views


Eu Yan Sang reels from S$3m blow in 2Q12

As it’s 1H12 net profit plunges 78% to a pitiful S$2 million.

According to a financial statement, Eu Yan Sang International Ltd posted a net loss of S$2.7 million for the three months ended 31 December 2011 (2QFY2012) due to an S$8.8 million impairment on its equity investment in its ASX‐listed associate company, HZL. Without such impairment, 2QFY2012 net profit would have been S$6.1 million. 1HFY2012revenue was up 7% to S$130.5 million while net profit dropped 78% to S$1.8 million.

Financial Performance
The Group’s 2QFY2012 revenue continued to grow, increasing 9% y‐o‐y to S$69.8 million on broad‐based revenue growth from all its main business segments of Retail‐TCM, Wholesale‐TCM and Clinic‐TCM. Maintaining gross margin at 51.4%, gross profit grew a similar 9% to S$35.9 million. In contrast, 2QFY2012 operating profit increased 1% to S$7.8 million due to higher distribution, selling and administrative expenses arising from expanding the retail network.

Operations Review
2QFY2012 Retail‐TCM revenue increased 8% to S$56.0 million demonstrating the continued consumer acceptance and trust of the Group’s brand in our markets. Bo Ying Compound, Bottled Bird’s Nest, Bak Foong Pills, Lingzhi Cracked Spores Capsules and Essence of Chicken remain the Group’s top selling products for the quarter. Wholesale‐TCM revenue increased 20% to S$8.5 million from the greater stock replenishment by wholesalers. Clinic‐TCM revenue grew 4% to S$4.5 million.

In local currency terms, all the Group’s three core markets posted revenue growth. Malaysia recorded the highest growth at 16% while Hong Kong and Singapore grew 12% and 4% respectively. The stronger Singapore dollar versus the Hong Kong dollar and Malaysian Ringgit trimmed their growth when viewed in Singapore dollars to 10% and 13% respectively.


 

Sign up for our weekly newsletter

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

Tags: Eu Yan Sang net loss 2Q12, Eu Yan Sang net profit 1H12, Bo Ying Compound, Bottled Bird’s Nest, Bak Foong Pills

COMPANIES FEATURED
Eu Yan Sang
TOP NEWS
SG’s inflation profile among the worst in Southeast Asia
SG’s inflation profile among the worst in Southeast Asia Policymakers are struggling to curb the high domestic inflation, with the April headline number expected to register at 5% YoY.
Are low-cost carriers Scoot and Tiger Airways tying the knot?
Domestic wholesale trade up by 3.4% in 1Q12
Tiger Airways Australia seen to continue its losing streak in 1Q13
75% of Singapore firm revenues now sourced abroad
Wilmar recovery in jeopardy as China capacity persists
Tiger Airways will roar back in 2013: CIMB
Ahoy, cruise ships: Marina Bay Cruise Centre Singapore ready for docking
Singapore still ranked as Asia’s Top Convention City in 2011
Banned! 80 stop-sale advisories issued
OTHER HEALTHCARE NEWS
Medtecs International's Director George Edwin Sycip resigns
Mr Sycip was also the Chairman of the Audit Committee and a member of the Nominating Committee and Remuneration Committee.
Medtecs International appoints Edwin Tay Cheok as Director
Great Eastern Holdings' S$263m profit boosts OCBC's books
Raffles Medical Group: No choice but to raise prices
Raffles Medical Group Director retires